+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alopecia Drugs - Global Market Trajectory & Analytics

  • ID: 5139396
  • Report
  • September 2020
  • Region: Global
  • 176 pages
  • Global Industry Analysts, Inc
1 of 2
Global Alopecia Drugs Market to Reach US$13.6 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Alopecia Drugs estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$13.6 Billion by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027. Oral Alopecia Drugs, one of the segments analyzed in the report, is projected to grow at a 5.8% CAGR to reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Topical Alopecia Drugs segment is readjusted to a revised 5.4% CAGR for the next 7-year period. This segment currently accounts for a 52.4% share of the global Alopecia Drugs market.

The U. S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5.2% CAGR for the Period of 2020-2027

The Alopecia Drugs market in the U. S. is estimated at US$2.8 Billion in the year 2020. The country currently accounts for a 29.49% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$2.4 Billion in the year 2027 trailing a CAGR of 5.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR while Rest of European market (as defined in the study) will reach US$2.4 Billion by the year 2027.

Injectable Alopecia Drugs Segment Corners a 4.7% Share in 2020

In the global Injectable Alopecia Drugs segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$354.9 Million in the year 2020 will reach a projected size of US$487.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.6 Billion by the year 2027. We bring years of research experience to this 9th edition of our report. The 176-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • The Himalaya Drug Company
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • Global Competitor Market Shares
  • Alopecia Drugs Competitor Market Share Scenario Worldwide (in %): 2018E
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 2: World Historic Review for Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 3: World 15-Year Perspective for Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
  • TABLE 4: World Current & Future Analysis for Oral Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 5: World Historic Review for Oral Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 6: World 15-Year Perspective for Oral Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 7: World Current & Future Analysis for Topical Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 8: World Historic Review for Topical Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 9: World 15-Year Perspective for Topical Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 10: World Current & Future Analysis for Injectable Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 11: World Historic Review for Injectable Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 12: World 15-Year Perspective for Injectable Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 13: World Current & Future Analysis for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 14: World Historic Review for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 15: World 15-Year Perspective for Men by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 16: World Current & Future Analysis for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 17: World Historic Review for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 18: World 15-Year Perspective for Women by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Alopecia Drugs Market Share (in %) by Company: 2018 & 2027
  • Market Analytics
  • TABLE 19: USA Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 20: USA Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 21: USA 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 22: USA Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 23: USA Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 24: USA 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
CANADA
  • TABLE 25: Canada Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 26: Canada Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 27: Canada 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 28: Canada Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 29: Canada Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 30: Canada 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
JAPAN
  • TABLE 31: Japan Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 32: Japan Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 33: Japan 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 34: Japan Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 35: Japan Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 36: Japan 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
CHINA
  • TABLE 37: China Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 38: China Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 39: China 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 40: China Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 41: China Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 42: China 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
EUROPE
  • Market Facts & Figures
  • European Alopecia Drugs Market: Competitor Market Share Scenario (in %) for 2018 & 2027
  • Market Analytics
  • TABLE 43: Europe Current & Future Analysis for Alopecia Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 44: Europe Historic Review for Alopecia Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 45: Europe 15-Year Perspective for Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
  • TABLE 46: Europe Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 47: Europe Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 48: Europe 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 49: Europe Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 50: Europe Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 51: Europe 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
FRANCE
  • TABLE 52: France Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 53: France Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 54: France 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 55: France Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 56: France Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 57: France 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
GERMANY
  • TABLE 58: Germany Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 59: Germany Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 60: Germany 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 61: Germany Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 62: Germany Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 63: Germany 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
ITALY
  • TABLE 64: Italy Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 65: Italy Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 66: Italy 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 67: Italy Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 68: Italy Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 69: Italy 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
UNITED KINGDOM
  • TABLE 70: UK Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 71: UK Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 72: UK 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 73: UK Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 74: UK Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 75: UK 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
REST OF EUROPE
  • TABLE 76: Rest of Europe Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 77: Rest of Europe Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 78: Rest of Europe 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 79: Rest of Europe Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 80: Rest of Europe Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 81: Rest of Europe 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
ASIA-PACIFIC
  • TABLE 82: Asia-Pacific Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 83: Asia-Pacific Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 84: Asia-Pacific 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 85: Asia-Pacific Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 86: Asia-Pacific Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 87: Asia-Pacific 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
REST OF WORLD
  • TABLE 88: Rest of World Current & Future Analysis for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 89: Rest of World Historic Review for Alopecia Drugs by Route of Administration (ROA) - Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 90: Rest of World 15-Year Perspective for Alopecia Drugs by Route of Administration (ROA) - Percentage Breakdown of Value Sales for Oral Alopecia Drugs, Topical Alopecia Drugs and Injectable Alopecia Drugs for the Years 2012, 2018 & 2027
  • TABLE 91: Rest of World Current & Future Analysis for Alopecia Drugs by Gender - Men and Women - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 92: Rest of World Historic Review for Alopecia Drugs by Gender - Men and Women Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 93: Rest of World 15-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men and Women for the Years 2012, 2018 & 2027
IV. COMPETITION
  • Total Companies Profiled: 52
Note: Product cover images may vary from those shown
Adroll
adroll